138 related articles for article (PubMed ID: 30794931)
1. Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades.
Kilari D; D'Souza A; Fraser R; Qayed M; Davila O; Agrawal V; Diaz MA; Chhabra S; Cerny J; Copelan E; Farhadfar N; Freytes CO; Gale RP; Ganguly S; Hildebrandt GC; Holmberg L; Kamble RT; Kapoor P; Lazarus H; Lee C; Murthy HS; Naik S; Nishihori T; Saad A; Savani BN; Seo S; Warwick A; Wirk B; Yared JA; Nieto Y; Hari P
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1099-1106. PubMed ID: 30794931
[TBL] [Abstract][Full Text] [Related]
2. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of patients with relapsed or refractory testicular nonseminous germ cell tumors treated with autologous stem cell transplantation.
Yilmaz F; Soyer N; Uslu R; Erdogan AP; Karaca B; Saydam G; Sahin F; Vural F
Indian J Cancer; 2017; 54(2):415-420. PubMed ID: 29469069
[TBL] [Abstract][Full Text] [Related]
4. What is the optimal high-dose treatment following autologous stem cell transplantation in relapsed or refractory germ cell cancer: a retrospective comparison of high-dose ICE and high-dose CE.
Yildiz B; Pinar Aral I; Balyemez U; Esin E; Erturk I; Acar R; Karadurmus N
J BUON; 2020; 25(2):1136-1140. PubMed ID: 32521917
[TBL] [Abstract][Full Text] [Related]
5. A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma.
Satwani P; Ahn KW; Carreras J; Abdel-Azim H; Cairo MS; Cashen A; Chen AI; Cohen JB; Costa LJ; Dandoy C; Fenske TS; Freytes CO; Ganguly S; Gale RP; Ghosh N; Hertzberg MS; Hayashi RJ; Kamble RT; Kanate AS; Keating A; Kharfan-Dabaja MA; Lazarus HM; Marks DI; Nishihori T; Olsson RF; Prestidge TD; Rolon JM; Savani BN; Vose JM; Wood WA; Inwards DJ; Bachanova V; Smith SM; Maloney DG; Sureda A; Hamadani M
Bone Marrow Transplant; 2015 Nov; 50(11):1416-23. PubMed ID: 26237164
[TBL] [Abstract][Full Text] [Related]
6. Low CD34
Hyder MA; Goebel WS; Ervin KD; Schwartz JE; Robertson MJ; Thakrar TC; Albany C; Farag SS
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1497-1504. PubMed ID: 29410296
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.
Smith SM; Burns LJ; van Besien K; Lerademacher J; He W; Fenske TS; Suzuki R; Hsu JW; Schouten HC; Hale GA; Holmberg LA; Sureda A; Freytes CO; Maziarz RT; Inwards DJ; Gale RP; Gross TG; Cairo MS; Costa LJ; Lazarus HM; Wiernik PH; Maharaj D; Laport GG; Montoto S; Hari PN
J Clin Oncol; 2013 Sep; 31(25):3100-9. PubMed ID: 23897963
[TBL] [Abstract][Full Text] [Related]
8. Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern Era.
Hamid AA; Markt SC; Vicier C; McDermott K; Richardson P; Ho VT; Sweeney CJ
Clin Genitourin Cancer; 2019 Feb; 17(1):58-64.e1. PubMed ID: 30309761
[TBL] [Abstract][Full Text] [Related]
9. Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis.
Casulo C; Friedberg JW; Ahn KW; Flowers C; DiGilio A; Smith SM; Ahmed S; Inwards D; Aljurf M; Chen AI; Choe H; Cohen J; Copelan E; Farooq U; Fenske TS; Freytes C; Gaballa S; Ganguly S; Jethava Y; Kamble RT; Kenkre VP; Lazarus H; Lazaryan A; Olsson RF; Rezvani AR; Rizzieri D; Seo S; Shah GL; Shah N; Solh M; Sureda A; William B; Cumpston A; Zelenetz AD; Link BK; Hamadani M
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1163-1171. PubMed ID: 29242111
[TBL] [Abstract][Full Text] [Related]
10. Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients.
Chhabra S; Thapa B; Szabo A; Konings S; D'Souza A; Dhakal B; Jerkins JH; Pasquini MC; Johnson BD; Hari PN; Hamadani M
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2011-2017. PubMed ID: 32717431
[TBL] [Abstract][Full Text] [Related]
11. Autologous hematopoietic cell transplantation for AML in first remission - An abandoned practice or promising approach?
Yeshurun M; Wolach O
Semin Hematol; 2019 Apr; 56(2):139-146. PubMed ID: 30926090
[TBL] [Abstract][Full Text] [Related]
12. High-Dose Chemotherapy and Autologous Stem Cell Transplant.
Adra N; Abonour R
Urol Clin North Am; 2019 Aug; 46(3):439-448. PubMed ID: 31277738
[TBL] [Abstract][Full Text] [Related]
13. Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation.
Nawas MT; Andreadis C; Martin TG; Wolf JL; Ai WZ; Kaplan LD; Mannis GN; Logan AC; Damon LE; Huang CY; Olin RL
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1218-1224. PubMed ID: 30708189
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts.
Adrianzen Herrera D; Kornblum N; Derman O; Bachier-Rodriguez L; Sica RA; Shastri A; Janakiram M; Verma A; Braunschweig I; Mantzaris I
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):516-521. PubMed ID: 31227357
[TBL] [Abstract][Full Text] [Related]
15. Length of Stay and Health Care Utilization Among Pediatric Autologous Hematopoietic Cell Transplantation Recipients.
Davis L; Yao Y; Jin Z; Moscoso S; Neunert C; Broglie L; Hall M; Bhatia M; George D; Garvin JH; Satwani P
Transplant Cell Ther; 2021 Jul; 27(7):613.e1-613.e7. PubMed ID: 33831624
[TBL] [Abstract][Full Text] [Related]
16. High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.
Adra N; Abonour R; Althouse SK; Albany C; Hanna NH; Einhorn LH
J Clin Oncol; 2017 Apr; 35(10):1096-1102. PubMed ID: 27870561
[TBL] [Abstract][Full Text] [Related]
17. Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.
Ayash LJ; Clarke M; Silver SM; Braun T; Uberti J; Ratanatharathorn V; Reynolds C; Ferrara J; Broun ER; Adams PT
Bone Marrow Transplant; 2001 May; 27(9):939-47. PubMed ID: 11436104
[TBL] [Abstract][Full Text] [Related]
18. Outcome of Allogeneic and Autologous Hematopoietic Cell Transplantation for High-Risk Peripheral T Cell Lymphomas: A Retrospective Analysis From a Chinese Center.
Huang H; Jiang Y; Wang Q; Guo L; Jin Z; Fu Z; Han Y; Sun A; Liu W; Ruan J; Wu D
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1393-1397. PubMed ID: 28478121
[TBL] [Abstract][Full Text] [Related]
19. First - line, non - cryopreserved autologous stem cell transplant for poor - risk germ - cell tumors: Experience in a developing country.
Leon-Rodriguez E; Rivera-Franco MM; Lacayo-Leñero D; Campos-Castro A; Meneses-Medina MI
Int Braz J Urol; 2019; 45(1):74-82. PubMed ID: 30325602
[TBL] [Abstract][Full Text] [Related]
20. [Use of high-dosage chemotherapy with autologous hematopoietic stem cell transplantation as a first-line therapy for the patients with poor-prognosis testicular tumors].
Marjanović S; Cerović S; Brajusković G
Vojnosanit Pregl; 2005 Mar; 62(3):213-8. PubMed ID: 15790050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
